Authors:
Christodoulou, C
Bafaloukos, D
Kosmidis, P
Samantas, E
Bamias, A
Papakostas, P
Karabelis, A
Bacoyiannis, C
Skarlos, DV
Citation: C. Christodoulou et al., Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases, ANN ONCOL, 12(2), 2001, pp. 249-254
Authors:
Fountzilas, G
Tsavdaridis, D
Kalogera-Fountzila, A
Christodoulou, C
Timotheadou, E
Kalofonos, C
Kosmidis, P
Adamou, A
Papakostas, P
Gogas, H
Stathopoulos, G
Razis, E
Bafaloukos, D
Skarlos, D
Citation: G. Fountzilas et al., Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase IIstudy, ANN ONCOL, 12(11), 2001, pp. 1545-1551
Authors:
Pectasides, D
Aravantinos, G
Kalofonos, H
Kiamouris, C
Bafaloukos, D
Xiros, N
Nicolaides, C
Visvikis, A
Dimopoulos, MA
Citation: D. Pectasides et al., Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 12(10), 2001, pp. 1417-1422
Authors:
Razis, E
Dimopoulus, AM
Bafaloukos, D
Papadimitriou, C
Kalogera-Fountzila, A
Kalofonos, H
Briassoulis, E
Samantas, E
Keramopoulos, A
Pavlidis, N
Kosmidis, P
Fountzilas, G
Citation: E. Razis et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer, CANCER INV, 19(2), 2001, pp. 137-144
Authors:
Fountzilas, G
Papadimitriou, C
Dafni, U
Bafaloukos, D
Skarlos, D
Moulopouos, LA
Razis, E
Kalofonos, HP
Aravantinos, G
Briassoulis, E
Papakostas, P
Abela, K
Gogas, E
Kosmidis, P
Pavlidis, N
Dimopoulos, MA
Citation: G. Fountzilas et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group, J CL ONCOL, 19(8), 2001, pp. 2232-2239
Authors:
Brountzos, EN
Panagiotou, IE
Bafaloukos, D
Magoulas, D
Kelekis, DA
Citation: En. Brountzos et al., Malignant fibrous histiocytoma of the trunk metastatic to the liver - Treatment with transcatheter intrahepatic chemoembolization, AM J CL ONC, 24(4), 2001, pp. 370-371
Authors:
Fountzilas, G
Papadimitriou, C
Aravantinos, G
Nicolaides, C
Stathopoulos, G
Bafaloukos, D
Kalofonos, H
Ekonomopoulos, T
Skarlos, D
Pavlidis, N
Dimopoulos, AM
Citation: G. Fountzilas et al., Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer, ONCOL-BASEL, 60(3), 2001, pp. 214-220
Authors:
Samonis, G
Thomakos, N
Liakakos, T
Macheras, A
Mandrekas, D
Kanavaki, S
Bafaloukos, D
Maraki, S
Citation: G. Samonis et al., Effects of cefepime and meropenem on the gastrointestinal colonization of surgical patients by Candida albicans, CHEMOTHERA, 47(5), 2001, pp. 350-353
Authors:
Nicolaides, C
Dimopoulos, MA
Samantas, E
Bafaloukos, D
Kalofonos, C
Fountzilas, G
Razi, E
Kosmidis, P
Pavlidis, N
Citation: C. Nicolaides et al., Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 11(7), 2000, pp. 873-875
Authors:
Aravantinos, G
Dimopoulos, MA
Kosmidis, P
Bafaloukos, D
Papadimitriou, C
Kiamouris, C
Pavlidis, N
Sikiotis, K
Papakostas, P
Skarlos, DV
Citation: G. Aravantinos et al., Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistantpaclitaxel-pretreated ovarian cancer, ANN ONCOL, 11(5), 2000, pp. 607-612
Authors:
Fountzilas, G
Nicolaides, C
Bafaloukos, D
Kalogera-Fountzila, A
Kalofonos, H
Samelis, G
Aravantinos, G
Pavlidis, N
Citation: G. Fountzilas et al., Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study, CANCER INV, 18(6), 2000, pp. 503-509
Authors:
Briasoulis, E
Kalofonos, H
Bafaloukos, D
Samantas, E
Fountzilas, G
Xiros, N
Skarlos, D
Christodoulou, C
Kosmidis, F
Pavlidis, N
Citation: E. Briasoulis et al., Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study, J CL ONCOL, 18(17), 2000, pp. 3101-3107
Authors:
Janinis, J
Giannakakis, T
Athanasiades, A
Fountzilas, G
Bafaloukos, D
Kosmidis, P
Nikolaides, K
Pavlidis, N
Skarlos, D
Citation: J. Janinis et al., A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study, TUMORI, 86(1), 2000, pp. 37-41
Authors:
Aravantinos, G
Skarlos, DV
Kosmidis, P
Georgoulias, V
Sgouros, I
Bafaloukos, D
Androulakis, N
Florou, S
Fountzilas, G
Citation: G. Aravantinos et al., Irinotecan (CPT-11) in patients with advanced colorectal cancer previouslytreated with 5-fluorouracil-based chemotherapy, CR R ONC H, 32(3), 1999, pp. 209-219
Authors:
Bafaloukos, D
Aravantinos, G
Samonis, G
Katsifis, G
Bakoyiannis, C
Skarlos, D
Kosmidis, P
Citation: D. Bafaloukos et al., Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic Cooperative Oncology Group Study, ONCOL-BASEL, 56(3), 1999, pp. 198-201